• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导致儿童急性淋巴细胞白血病患者 asparaginase 相关毒性的临床和人口统计学因素。

Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia.

机构信息

School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.

Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

出版信息

Leuk Lymphoma. 2022 Dec;63(12):2948-2954. doi: 10.1080/10428194.2022.2102621. Epub 2022 Jul 27.

DOI:10.1080/10428194.2022.2102621
PMID:35895075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9745725/
Abstract

A total of 548 patients (age range: 1-22 years, 60.4% Hispanic, 55.8% male) diagnosed with acute lymphoblastic leukemia were reviewed for pegaspargase-associated hypersensitivity (14.8%), hyperbilirubinemia (9.7%), venous thromboembolism (VTE, 9.7%), and pancreatitis (5.3%). Odds ratios (OR) and 95% confidence intervals (CI) evaluated associations between clinical factors and each toxicity, cumulative number of toxicities, and toxicity clusters identified using k-mode analysis. Most (68.9%) did not experience any toxicity, 24.6% experienced one toxicity, and 6.3% two or more. Age >10 years was associated with hyperbilirubinemia (OR = 3.83; 95% CI: 1.64-8.95), pancreatitis (OR = 3.72; 95% CI: 1.29-10.68), VTE (OR = 4.65; 95% CI: 1.96-11.02), and cumulative toxicity burden (OR = 3.28, 95% CI: 1.97-5.47); high-risk therapy with hypersensitivity (OR 2.25; 95% CI 1.25-4.05); and overweight with cumulative toxicity burden (OR = 1.76, 95% CI: 1.20-2.57). Eight unique toxicity profiles were identified. Older age, overweight, and treatment intensity contribute to pegaspargase-associated toxicities.

摘要

共有 548 名(年龄范围:1-22 岁,60.4%为西班牙裔,55.8%为男性)被诊断为急性淋巴细胞白血病的患者接受了培门冬酶相关过敏反应(14.8%)、高胆红素血症(9.7%)、静脉血栓栓塞症(VTE,9.7%)和胰腺炎(5.3%)的评估。采用 k-均值分析评估了临床因素与每种毒性、累积毒性数以及毒性簇之间的关联。大多数(68.9%)患者没有发生任何毒性,24.6%的患者发生了 1 种毒性,6.3%的患者发生了 2 种或更多毒性。年龄>10 岁与高胆红素血症(OR=3.83;95%CI:1.64-8.95)、胰腺炎(OR=3.72;95%CI:1.29-10.68)、VTE(OR=4.65;95%CI:1.96-11.02)和累积毒性负担(OR=3.28,95%CI:1.97-5.47)相关;高风险治疗伴过敏反应(OR=2.25;95%CI 1.25-4.05);超重与累积毒性负担(OR=1.76,95%CI:1.20-2.57)相关。确定了 8 种独特的毒性特征。年龄较大、超重和治疗强度是培门冬酶相关毒性的原因。

相似文献

1
Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia.导致儿童急性淋巴细胞白血病患者 asparaginase 相关毒性的临床和人口统计学因素。
Leuk Lymphoma. 2022 Dec;63(12):2948-2954. doi: 10.1080/10428194.2022.2102621. Epub 2022 Jul 27.
2
Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
.天冬酰胺酶毒性:急性淋巴细胞白血病患者的识别与管理
Clin J Oncol Nurs. 2017 Oct 1;21(5):E248-E259. doi: 10.1188/17.CJON.E248-E259.
3
The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance.在聚乙二醇天冬酰胺酶不耐受后,将欧文氏菌天冬酰胺酶用于成年急性淋巴细胞白血病患者。
Leuk Res. 2016 Nov;50:17-20. doi: 10.1016/j.leukres.2016.08.014. Epub 2016 Aug 26.
4
Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study.PEG 天冬酰胺酶间断给药与连续给药以减少天冬酰胺酶相关毒性:一项 NOPHO ALL2008 随机研究。
J Clin Oncol. 2019 Jul 1;37(19):1638-1646. doi: 10.1200/JCO.18.01877. Epub 2019 Apr 12.
5
Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemia.纳入成人急性淋巴细胞白血病儿科治疗方案的聚乙二醇化天冬酰胺酶重复给药的毒性特征。
Eur J Haematol. 2016 Apr;96(4):375-80. doi: 10.1111/ejh.12600. Epub 2015 Jun 25.
6
Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.儿童急性淋巴细胞白血病 NOPHO ALL2008 方案中与门冬酰胺酶相关的胰腺炎。
Br J Haematol. 2014 Apr;165(1):126-33. doi: 10.1111/bjh.12733. Epub 2014 Jan 15.
7
Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia.40 岁及以上成人急性淋巴细胞白血病患者使用培门冬酶的耐受性和毒性。
Leuk Lymphoma. 2021 Jan;62(1):176-184. doi: 10.1080/10428194.2020.1824068. Epub 2020 Sep 26.
8
Trypsin-encoding variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report.胰蛋白酶编码变异影响急性淋巴细胞白血病患儿伴发门冬酰胺酶相关胰腺炎的风险: Ponte di Legno 毒性工作组报告。
Haematologica. 2019 Mar;104(3):556-563. doi: 10.3324/haematol.2018.199356. Epub 2018 Nov 22.
9
Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age.急性淋巴细胞白血病中与天冬酰胺酶相关的胰腺炎:来自北欧小儿肿瘤协作组 ALL2008 研究 1-45 岁患者的结果。
J Clin Oncol. 2020 Jan 10;38(2):145-154. doi: 10.1200/JCO.19.02208. Epub 2019 Nov 26.
10
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.PEG 化埃希氏菌门冬酰胺酶、培格司他治疗对培门冬酶过敏的小儿急性淋巴细胞白血病/淋巴母细胞淋巴瘤患者的结局:来自儿童肿瘤学组的报告。
Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26873. Epub 2017 Nov 1.

引用本文的文献

1
Changes in asparaginase exposure and toxicity profiles in obese pediatric acute lymphoblastic leukemia patients.肥胖儿童急性淋巴细胞白血病患者中天冬酰胺酶暴露量及毒性特征的变化
Haematologica. 2025 Aug 1;110(8):1849-1853. doi: 10.3324/haematol.2024.285788. Epub 2025 Feb 13.
2
Real-World Presentation and Prognostic Effect of Allogeneic Blood Transfusion during the Intensive Induction Phase in Pediatric Acute Lymphoblastic Leukemia.儿童急性淋巴细胞白血病强化诱导期异体输血的真实世界表现及预后影响
Cancers (Basel). 2023 Sep 7;15(18):4462. doi: 10.3390/cancers15184462.
3
Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding. Hispanic 成人和儿科急性淋巴细胞白血病患者的 asparaginase 毒性:现有认识。
Expert Opin Drug Metab Toxicol. 2023 Jan-Jun;19(6):357-366. doi: 10.1080/17425255.2023.2233412.
4
Analysis of gene mutations in adverse events during first induction chemotherapy in childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病首次诱导化疗期间不良事件的基因突变分析
Transl Pediatr. 2023 Jan 31;12(1):56-67. doi: 10.21037/tp-22-683. Epub 2023 Jan 13.

本文引用的文献

1
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.儿童肿瘤协作组试验 AALL1231:一项测试硼替佐米在新诊断的 T 细胞急性淋巴细胞白血病和淋巴瘤中的 III 期临床试验。
J Clin Oncol. 2022 Jul 1;40(19):2106-2118. doi: 10.1200/JCO.21.02678. Epub 2022 Mar 10.
2
A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment.白血病电子病历网络关于小儿急性淋巴细胞白血病治疗期间肝毒性风险的报告。
Haematologica. 2022 May 1;107(5):1185-1188. doi: 10.3324/haematol.2021.279805.
3
Obesity as a predictor of treatment-related toxicity in children with acute lymphoblastic leukaemia.肥胖症作为儿童急性淋巴细胞白血病治疗相关毒性的预测因子。
Br J Haematol. 2022 Mar;196(5):1239-1247. doi: 10.1111/bjh.17936. Epub 2021 Nov 2.
4
Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932.标准风险 B 淋巴细胞白血病中减少长春新碱和地塞米松脉冲治疗的频率可获得良好的结果:来自儿童肿瘤学组 AALL0932 的结果。
J Clin Oncol. 2021 May 1;39(13):1437-1447. doi: 10.1200/JCO.20.00494. Epub 2021 Jan 7.
5
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.儿童肿瘤学组 AALL0434:一项测试新诊断 T 细胞急性淋巴细胞白血病中奈拉滨的 III 期随机临床试验。
J Clin Oncol. 2020 Oct 1;38(28):3282-3293. doi: 10.1200/JCO.20.00256. Epub 2020 Aug 19.
6
Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131.鞘内三联疗法与鞘内甲氨蝶呤对高危 B 淋巴细胞白血病无病生存的影响:儿童肿瘤学组研究 AALL1131。
J Clin Oncol. 2020 Aug 10;38(23):2628-2638. doi: 10.1200/JCO.19.02892. Epub 2020 Jun 4.
7
Cancer Progress and Priorities: Childhood Cancer.癌症进展与优先事项:儿童癌症。
Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1081-1094. doi: 10.1158/1055-9965.EPI-19-0941.
8
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.天冬酰胺酶停用对儿童急性淋巴细胞白血病预后的影响:来自儿童肿瘤学组的报告
J Clin Oncol. 2020 Jun 10;38(17):1897-1905. doi: 10.1200/JCO.19.03024. Epub 2020 Apr 10.
9
Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age.急性淋巴细胞白血病中与天冬酰胺酶相关的胰腺炎:来自北欧小儿肿瘤协作组 ALL2008 研究 1-45 岁患者的结果。
J Clin Oncol. 2020 Jan 10;38(2):145-154. doi: 10.1200/JCO.19.02208. Epub 2019 Nov 26.
10
Incidence and predictors of treatment-related conjugated hyperbilirubinemia during early treatment phases for children with acute lymphoblastic leukemia.儿童急性淋巴细胞白血病早期治疗期间与治疗相关的结合性高胆红素血症的发生率和预测因素。
Pediatr Blood Cancer. 2020 Feb;67(2):e28063. doi: 10.1002/pbc.28063. Epub 2019 Nov 17.